Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.

about

Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?Growth and Immune Evasion of Lymph Node Metastasis.

P2860

Q47194123-20C48BA3-BD24-407E-B350-FFBC8B2C0D87 Q55364617-4A4AF3D8-816B-4A9A-8143-E3216D829E34

P2860

Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.

Item

http://www.wikidata.org/entity/Q46646887

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.

@en

Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.

@nl

type

Item

label

Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.

@en

Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.

@nl

prefLabel

Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.

@en

Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.

@nl

P1476

Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.

@en

P2093

Anwen Williams

http://www.w3.org/2001/XMLSchema#string

Awen Gallimore

http://www.w3.org/2001/XMLSchema#string

Carl F Ware

http://www.w3.org/2001/XMLSchema#string

Emily J Colbeck

http://www.w3.org/2001/XMLSchema#string

Emma Jones

http://www.w3.org/2001/XMLSchema#string

James P Hindley

http://www.w3.org/2001/XMLSchema#string

Kathryn Smart

http://www.w3.org/2001/XMLSchema#string

Lee Parry

http://www.w3.org/2001/XMLSchema#string

Molly Browne

http://www.w3.org/2001/XMLSchema#string

Ralph Schulz

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding high endothelial venules: Lessons for cancer immunology

Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses.

Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules

Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity

Development and maturation of secondary lymphoid tissues.

Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors

P304

1005-1015

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/2326-6066.CIR-17-0131

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ann Ager

Andrew Godkin

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28947544

http://www.w3.org/2001/XMLSchema#string

P932

5668144

http://www.w3.org/2001/XMLSchema#string

Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.

about

P2860

P2860

Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932